Andrew Phillips

Research interests

Publications

• Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models

  The Lancet HIV · 2020 · 10.1016/s2352-3018(20)30211-3

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30418-0

• Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

  JAMA · 2016 · https://doi.org/10.1001/jama.2016.5148

• Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00056-2

• HIV infection

  Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.35

• Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

  The Lancet · 2014 · 10.1016/s0140-6736(14)60604-8

• Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population

  The Lancet HIV · 2014 · 10.1016/s2352-3018(14)70018-9

• Life expectancy living with HIV

  Current Opinion in Infectious Diseases · 2012 · 10.1097/qco.0b013e32835ba6b1

• HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa

  PLoS Medicine · 2012 · 10.1371/journal.pmed.1001245

• Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

  AIDS · 2012 · 10.1097/qad.0b013e32835cae9c

• Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

  BMJ · 2011 · 10.1136/bmj.d6016

• Projected life expectancy of people with HIV according to timing of diagnosis

  AIDS · 2011 · 10.1097/qad.0b013e32834dcec9

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  The Lancet Infectious Diseases · 2011 · https://doi.org/10.1016/s1473-3099(11)70032-9

• Late presentation of HIV infection: a consensus definition

  HIV Medicine · 2010 · 10.1111/j.1468-1293.2010.00857.x

• Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

  European Journal of Cardiovascular Prevention & Rehabilitation · 2010 · 10.1097/hjr.0b013e328336a150

• Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

  AIDS · 2010 · 10.1097/qad.0b013e328339fe53

• Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

  The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/649897

• Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients

  Diabetes Care · 2008 · 10.2337/dc07-2013

• Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

  The Journal of Infectious Diseases · 2005 · 10.1086/432762

• Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

  AIDS · 2003 · https://doi.org/10.1097/00002030-200305230-00010

• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

  The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)09411-4

• Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

  AIDS · 2001 · 10.1097/00002030-200107060-00007

• Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

  The Lancet · 2001 · 10.1016/s0140-6736(00)04056-3

• Why do people sue doctors? A study of patients and relatives taking legal action

  The Lancet · 1994 · 10.1016/s0140-6736(94)93062-7

• ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES

  The Lancet · 1989 · 10.1016/s0140-6736(89)92042-4

Current projects

No projects listed.